Bruna Rocha combines solid technical expertise in life sciences and healthcare with a sector-focused, business-oriented approach tailored to her clients' needs.

She works on corporate transactions and joint ventures with and among pharmaceutical companies, biotechs, medtechs, CROs, and hospitals; structures partnerships with payers for value-based models and risk-sharing arrangements; and negotiates R&D, co-development, and licensing agreements. Bruna ensures end-to-end regulatory compliance, covering registration pathways and submissions. She conducts negotiations with investors, regulatory authorities, and C-level executives to accelerate go-to-market, access, and reimbursement, with clear metrics, objective communication, and agile execution. A reference in the sector, she integrates strategy, regulation, and business, from clinical trials to post-market, in order to scale value with safety, compliance, and speed.

Experience

Bruna Rocha advises a broad, multidisciplinary client base across the entire healthcare value chain, from pharmaceutical companies, fine chemical companies, and biotechs to medtechs, digital health, CROs, hospitals, and agribusiness initiatives linked to biotechnology, translating strategic objectives into legal, regulatory, and transactional structures that unlock growth with controlled risk. Her work connects the laboratory to the market, aligning transaction design, intellectual property management, and regulatory governance to enable cycles of innovation, scalability, and monetization.

With a focus on value creation and risk mitigation, Bruna leads the structuring and negotiation of corporate transactions, asset deals, joint ventures, commercial alliances, and investment platforms, in addition to licensing, R&D partnerships, and spin-offs. Her work encompasses the incorporation of companies with regulated activities, robust compliance architectures, and complex restructurings, integrating regulatory diligence, liability for healthcare products and services, and reputational safeguards, always guided by performance metrics and clear governance.

At the interface between business, science, and regulation, Bruna works side by side with C-level executives, investors, developers, and healthcare professionals to orchestrate the full cycle of development, approval, and market access, articulating regulatory strategy, tax efficiency, privacy and data protection, and patient quality and safety. Her experience also encompasses AI in healthcare, SaMD, interoperability and information exchange, IoMT, wearables, bioprinting, and digital care models, converting technological advances into regulatory impact and transactional value, with clear pathways for registration, reimbursement, and sustainable expansion.

Specialties

Sectors: Agribusiness / Food & Beverages / Consumer Goods & Retail / Life Sciences & Healthcare / Technology

Areas of Practice Commercial Contracts / Government Contracting / EGVC / Project Finance / Regulatory and Public Policies / Corporate/M&A

Qualifications

• Graduação em Direito pela Universidade de Barretos
• “Scaling Excellence through Innovation", Stanford University
• "Principles of Economics", Stanford University
• "Essentials of Program Strategy and Evaluation", Stanford University
• "How Software Ate Finance", Stanford University
• "Project Management Life Cycle", Rochester Institute of Technology (RITx)

Alliances and Associations

• Ordem dos Advogados do Brasil, Seccionais de São Paulo e do Rio de Janeiro
• International Bar Association (IBA)
• Brazilian-American Chamber of Commerce

Languages

Portuguese, English, Spanish